Sacral Neuromodulation in Multiple Sclerosis: The NEMISIS Study
- PMID: 40037970
- DOI: 10.1016/j.euf.2025.02.009
Sacral Neuromodulation in Multiple Sclerosis: The NEMISIS Study
Abstract
Recent studies have shown promising sacral neuromodulation (SNM) results in neurogenic overactive bladder caused by multiple sclerosis. In the first half of 2025 we aim to start including patients in a multicentre, randomised controlled trial to test the hypothesis that SNM has a therapeutic benefit in this setting.
Copyright © 2025 European Association of Urology. Published by Elsevier B.V. All rights reserved.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
